AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · IEX Real-Time Price · USD
33.70
-0.75 (-2.18%)
At close: Jul 19, 2024, 4:00 PM
34.07
+0.37 (1.10%)
Pre-market: Jul 22, 2024, 7:05 AM EDT
AnaptysBio Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for AnaptysBio stock have an average target of 51.89, with a low estimate of 21 and a high estimate of 80. The average target predicts an increase of 53.98% from the current stock price of 33.70.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AnaptysBio stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 2 | 4 | 4 | 4 | 5 |
| Hold | 3 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $55 | Strong Buy | Initiates | $55 | +63.20% | Jul 22, 2024 |
| JP Morgan | JP Morgan | Hold → Buy Upgrades $29 → $69 | Hold → Buy | Upgrades | $29 → $69 | +104.75% | Jul 19, 2024 |
| Wedbush | Wedbush | Buy Reiterates $34 | Buy | Reiterates | $34 | +0.89% | May 10, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $47 | Buy | Initiates | $47 | +39.47% | Apr 16, 2024 |
| Wells Fargo | Wells Fargo | Buy Initiates $56 | Buy | Initiates | $56 | +66.17% | Apr 11, 2024 |
Financial Forecast
Revenue This Year
43.43M
from 17.16M
Increased by 153.16%
Revenue Next Year
19.75M
from 43.43M
Decreased by -54.52%
EPS This Year
-5.97
from -6.08
EPS Next Year
-6.55
from -5.97
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 83.1M | 49.1M | 86.8M | 88.2M | 177.7M |
| Avg | 43.4M | 19.8M | 31.3M | 27.1M | 91.0M |
| Low | 7.0M | n/a | n/a | n/a | 13.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 384.6% | 13.1% | 339.2% | 181.8% | 555.6% |
| Avg | 153.2% | -54.5% | 58.5% | -13.4% | 235.6% |
| Low | -59.0% | - | - | - | -49.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -4.84 | -4.97 | -5.03 | -6.17 | -4.52 |
| Avg | -5.97 | -6.55 | -6.53 | -7.13 | -6.58 |
| Low | -6.69 | -7.35 | -7.55 | -7.95 | -8.43 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.